Novo Integrated Sciences, Inc. Common Stock
NVOS
NVOS was delisted on the 5th of November, 2024.
14 hedge funds and large institutions have $424K invested in Novo Integrated Sciences, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 3 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 2
0.84% less ownership
Funds ownership: 5.73% → 4.9% (-0.84%)
13% less funds holding
Funds holding: 16 → 14 (-2)
48% less capital invested
Capital invested by funds: $814K → $424K (-$390K)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
XT
XTX Topco
George Town,
Cayman Islands
|
+$18.4K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$12K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.38K |
| 4 |
JP Morgan Chase
New York
|
+$9 |
| 5 |
Wells Fargo
San Francisco,
California
|
+$5 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$95.8K |
| 2 |
VF
Virtu Financial
New York
|
-$16.2K |
| 3 |
Jane Street
New York
|
-$13.2K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$9.95K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$184 |
NVOS Hedge Fund Activity: Q1 2024 in Review
14 of the 6,960 institutional investors tracked by Wall St. Rank reported a position in Novo Integrated Sciences, Inc. Common Stock (NVOS) for Q1 2024, worth a combined $424K — down 48% from $814K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of NVOS and 1 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 4 added.
The largest buyer was XTX Topco, adding an estimated $18.4K. The largest seller was Citadel Advisors, exiting entirely with an estimated $95.8K sold.
- 14 institutional investors held Novo Integrated Sciences, Inc. Common Stock (NVOS) as of Q1 2024, down from 16 in Q4 2023.
- Funds reported $424K of Novo Integrated Sciences, Inc. Common Stock stock for Q1 2024, down 48% quarter-over-quarter.
- 1 fund opened new Novo Integrated Sciences, Inc. Common Stock positions in Q1 2024 and 3 closed out, a net change of -2 holders.
- The largest Novo Integrated Sciences, Inc. Common Stock buyer in Q1 2024 was XTX Topco, an estimated $18.4K added.
- The largest Novo Integrated Sciences, Inc. Common Stock seller in Q1 2024 was Citadel Advisors, an estimated $95.8K sold.
Based on aggregated 13F filings for Q1 2024.